Alpa Laboratories Limited
Symbool: ALPA.BO
BSE
90.5
INRMarktprijs vandaag
10.3959
Koers/Winst Verhouding
-0.9674
Koers/Winst Groei Verhouding
1.90B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Alpa Laboratories Limited (ALPA-BO) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 808.4 | 702.7 | 424.9 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | 720.3 | 687 | 406.9 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 501.4 | 430.8 | 381.4 | |||||||||||||||
balance-sheet.row.inventory | 0 | 126.4 | 154.6 | 165.6 | |||||||||||||||
balance-sheet.row.other-current-assets | 0 | 81.6 | 72.7 | 107.8 | |||||||||||||||
balance-sheet.row.total-current-assets | 0 | 1491.2 | 1380.1 | 1210.9 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 69.6 | 92.2 | 87.3 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0.8 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0.8 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 96.5 | 61.5 | 104.9 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 9.3 | 0 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 14.5 | 8.3 | 0 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 181.4 | 172.3 | 192.8 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 0 | 1672.7 | 1552.4 | 1403.7 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 150.6 | 149.2 | 247.3 | |||||||||||||||
balance-sheet.row.short-term-debt | 0 | 15.3 | 37.2 | 1.8 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 22.8 | 25.7 | 2.9 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 7.8 | 21.2 | 0.1 | |||||||||||||||
Deferred Revenue Non Current | 0 | 0 | -25.7 | -2.2 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 0 | 73.4 | 67.4 | 38.8 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 7.8 | 21.2 | 0.1 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-liab | 0 | 326.9 | 335.1 | 327.3 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0 | 210.4 | 210.4 | 210.4 | |||||||||||||||
balance-sheet.row.retained-earnings | 0 | 585.8 | 457.3 | 316.4 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 760 | 760 | 760 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -210.4 | -210.4 | -210.4 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1345.8 | 1217.3 | 1076.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1672.7 | 1552.4 | 1403.7 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-equity | 0 | 1345.8 | 1217.3 | 1076.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||
Total Investments | 0 | 77.7 | 74.7 | 101.5 | |||||||||||||||
balance-sheet.row.total-debt | 0 | 23 | 58.5 | 1.9 | |||||||||||||||
balance-sheet.row.net-debt | 0 | -65.1 | 42.7 | -16.1 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 156.8 | 195.6 | 107.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 13.3 | 16.6 | 12.3 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -8 | 14.5 | -103.4 | |||||||||||||||
cash-flows.row.account-receivables | 0 | -66.4 | -0.3 | -185 | |||||||||||||||
cash-flows.row.inventory | 0 | 28.2 | 11 | -40.1 | |||||||||||||||
cash-flows.row.account-payables | 0 | 19.8 | -78.9 | 127.2 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | 10.3 | 82.8 | -5.5 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -73 | -127.3 | -33.8 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -11.3 | -21.9 | -32.2 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | -5 | 42.3 | 3.7 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -0.3 | -191.8 | 7.9 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 12.3 | 15.4 | 79.1 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 25.5 | -0.1 | 0.1 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 21.3 | -156.1 | 58.6 | |||||||||||||||
cash-flows.row.debt-repayment | 0 | -35.4 | -21.2 | -1.8 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 0 | -2.5 | 75.6 | 3.7 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -37.9 | 54.4 | 1.9 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | -0.1 | |||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 72.4 | -2.3 | 43.4 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 88.1 | 15.8 | 105.1 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 15.8 | 18 | 61.7 | |||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 89 | 99.4 | -17 | |||||||||||||||
cash-flows.row.capital-expenditure | 0 | -11.3 | -21.9 | -32.2 | |||||||||||||||
cash-flows.row.free-cash-flow | 0 | 77.8 | 77.5 | -49.2 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 924.1 | 1105.1 | 964.1 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 615 | 760.9 | 647.6 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 309.1 | 344.3 | 316.6 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0 | 28.8 | 1.5 | 0.5 | |||||||||||||||
income-statement-row.row.operating-expenses | 0 | 235.5 | 248.8 | 219.4 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 850.5 | 1009.7 | 867 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 10.4 | 14.6 | 6.5 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.8 | 1.1 | 0.3 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 81 | 101.1 | 41.7 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 28.8 | 1.5 | 0.5 | |||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 81 | 101.1 | 41.7 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.8 | 1.1 | 0.3 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 13.3 | 16.6 | 12.3 | |||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 0 | 67.5 | 79.6 | 69 | |||||||||||||||
income-statement-row.row.income-before-tax | 0 | 158.9 | 195.6 | 107.9 | |||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 33.1 | 54.7 | 35.4 | |||||||||||||||
income-statement-row.row.net-income | 0 | 125.8 | 140.9 | 72.5 |
Vaak gestelde vragen
Wat is Alpa Laboratories Limited (ALPA.BO) totale activa?
Alpa Laboratories Limited (ALPA.BO) totale activa is 1672699000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.350.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.157.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.135.
Wat is Alpa Laboratories Limited (ALPA.BO) nettowinst (netto-inkomen)?
De nettowinst is 125828000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 23040000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 235520000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.